✦ LIBER ✦

Safety of aromatase inhibitors in the adjuvant setting

✍ Scribed by Edith A. Perez

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 309 KB
Volume: 105
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9704-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of aromatase inhibitors in the ad

Safety of aromatase inhibitors in the adjuvant setting

✍ Edith A. Perez 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 61 KB

The use of aromatase inhibitors in adjuv

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

✍ Walter Jonat; Felix Hilpert; Nicolai Maass 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 250 KB

Increasing protection after tamoxifen: i

Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials

✍ Carsten Rose 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 443 KB

Adjuvant aromatase inhibitor therapy for

Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data

✍ G. Grana 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract Tamoxifen is the established adjuvant treatment for postmenopausal women with hormone‐sensitive early breast cancer. However, the side‐effects associated with tamoxifen therapy have prompted a search for safer and potentially more effective endocrine agents. Results from randomized tria

One size does not fit all: quality of li

One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy

✍ N. Lynn Henry; Vered Stearns 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 94 KB

Safety profiles of aromatase inhibitors

Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer

✍ Yutaka Yamamoto; Hirotaka Iwase 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 254 KB